AFP and hepatocellular carcinoma: For example, alpha‐fetoprotein (AFP), a commonly used biomarker for HCC, may not be elevated in some patients with HCC and can yield false‐positive results in certain benign liver diseases, thereby compromising diagnostic reliability [40].